Journal: Annals of Translational Medicine
Article Title: TGR5 protects against cholestatic liver disease via suppressing the NF-κB pathway and activating the Nrf2/HO-1 pathway
doi: 10.21037/atm-21-2631
Figure Lengend Snippet: TGR5−/− BDL mice showed increased oxidative stress and pro-inflammatory response. WT or TGR5−/− mice underwent BDL. (A) MDA and CAT activities in liver tissues on Day 10 (n=3 per group); (B) TNF-α and IL-6 level on Day 1, 3, 7, and 10 measured by ELISA (n=3 per group); (C) TGR5, TLR4, and HO-1 expression in liver on Day 10 (n=3 per group); (D) the expression levels of NF-κB (nuclear and cytoplasmic) and Nrf2 (nuclear and cytoplasmic) in liver on day 10 (n=3 per group). **P<0.01, ***P<0.001 (vs. control); #P<0.05, ##P<0.01 (vs. WT). BDL, bile duct ligation. MDA, malondialdehyde; CAT, catalase.
Article Snippet: Lentivirus preparation Short hairpin RNA (shRNA) oligos targeting mouse Nrf2 ( Table S1 ) were cloned into pLKO.1 vector (OriGene, Rockville, MD).
Techniques: Enzyme-linked Immunosorbent Assay, Expressing, Control, Ligation